Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4674

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4cd7b19c D80f 4c80 8795 F4c9566ab59a 01)

Chemical structure of bupropion hydrochloride showing the chloro-substituted aromatic ring and keto groups attached, along with the hydrochloride component as indicated by HCl.*

FDA Label Image

Mm1 (Bupropion HCl 150mg 70518 4674 00)

Label for bupropion hydrochloride extended-release tablet, 150 mg strength, in a quantity of 30 tablets. The label includes storage instructions, manufacturer Rising Pharma, Inc. (NJ), and repackager Remedy Repack Inc. (PA). The label notes it is a prescription-only drug and instructs to protect it from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.